Clinical Trial Update: The Effects of Semaglutide on Body Composition and Performance in Military Personnel [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating semaglutide for obesity in military personnel has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: United States Army Research Institute of Environmental Medicine | Conditions: Obesity | Phase 4 | Status: WITHDRAWN